| Target Professions: | DO, MD, Nurse Practitioner, Physician Associate/Assistant |
| Target Specialties: | Pulmonary/Respiratory Physician |
| Credits Available: | 3.50 AMA PRA Category 1 Credit™ |
Chronic obstructive pulmonary disease (COPD), the third leading cause of death worldwide, is a heterogeneous lung condition characterized by chronic respiratory symptoms caused by persistent airflow limitation due to airway and alveolar abnormalities. Initial COPD management relies on bronchodilators with the addition of inhaled corticosteroids for those at high risk for exacerbations. However, up to half of patients on triple therapy still experience exacerbations, highlighting a need for new therapies. Biologic therapy targeting type 2 inflammation, which is common in COPD and associated with exacerbation risk, has recently been approved for clinical use as add-on maintenance treatment of adult patients with inadequately controlled COPD and an eosinophilic phenotype. This educational program is designed to get pulmonology experts up to date on these rapid treatment advances for COPD as well as to bolster standard-of-care fundamentals.
Answer the following questions to assess your knowledge of COPD management.
This module covers the basics of COPD management, including assessment, treatment across the spectrum of disease, and the need for new therapies.
This module covers recent advances in COPD management, including an update on pathophysiology, the emergence of biologic therapies for the treatment of this disease, and future directions.
Now that you have reviewed the self-study modules, answer the following questions to assess your knowledge of COPD management.
This activity presents the case of a 61-year-old woman with COPD and explores clinical approaches to managing her condition as she continues to experience recurrent exacerbations over a 3-year period.
In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the care of your patients with COPD.
This discussion will consist of: 1) review of the self-study modules; 2) examination of the case-based Group Challenge Assignments; and, 3) assessment of Action Plans and barriers to their implementation, including real-time feedback from the Group Leader and other Group Members.
